Skip to main content

885 publications

Name Date Type Actions

Balo new information

Balo new information

Shareholders´s Meeting

Number of voting rights and shares making of the share capital

Information regarding the total number of voting rights and shares making of the share capital  - J-21 before AGM as per articles L233-8-II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Shareholders´s Meeting

Annual general meeting 2022 - brochure

Shareholders´s Meeting

Availability of the 2021 universal registration document

Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022.

Public releases

Vote by post / proxy form

Vote by post of proxy form for annual general meeting on May 19, 2022

Shareholders´s Meeting

General annual meeting - may 19 2022

Annual General Meeting on May 19, 2022 - convocation

Shareholders´s Meeting

Q1 2022 SALES: €135M

Q1 2022 SALES: €135M
(UP 5.5% AS REPORTED, UP 2.2% AT CONSTANT EXCHANGE RATES)
Q1 2022 ESSENTIALS SALES: €77M
(UP 8.1% AS REPORTED, UP 5.5 AT CONSTANT EXCHANGE RATES)

Public releases

Buyback programs - march 2022

Monthly communication regarding buyback programs

Monthly communication regarding buyback programs

Monthly information regarding the total number of voting rights and shares - march 2022

Monthly information regarding the total number of voting rights and shares making of the share capital

as per articles L233-8-II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

Voting rights

2021 Annual results

ALL FINANCIAL INDICATORS UP.
Annual sales: €521m (up 21.9% as reported).
Essentials sales: €296m (up 34.0% as reported).
EBIT before depreciation of acquired assets: €101m (up 54.5%).
Net income - Group share: €63m (up 226.9%).

Public releases